Perspective Therapeutics (CATX) Leases (2011 - 2026)

Perspective Therapeutics' Leases history runs 10 years deep, the most recent figure standing at $2.4 million for Q1 2026.

• In Q1 2026, Leases rose 22.57% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $2.4 million (up 22.57% YoY), while the FY2025 annual figure was $1.5 million, down 32.28% from the prior year.
• Leases came in at $2.4 million for Q1 2026 at Perspective Therapeutics, up from $1.5 million in the prior quarter.
• In the past five years, Leases ranged from a high of $2.4 million in Q1 2026 to a low of $309000.0 in Q1 2023.
• A 5-year average of $1.4 million and a median of $1.5 million in 2023 frame the typical range for Leases.
• On a YoY basis, Leases climbed as much as 243.6% in 2023 and fell as far as 46.45% in 2023.
• Perspective Therapeutics' Leases stood at $445000.0 in 2022, then soared by 67.87% to $747000.0 in 2023, then surged by 196.52% to $2.2 million in 2024, then plunged by 32.28% to $1.5 million in 2025, then jumped by 62.93% to $2.4 million in 2026.
• According to Business Quant data, Leases over the past three periods registered $2.4 million, $1.5 million, and $1.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison